SUNNYVALE, Calif., Oct. 9, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Klinikum rechts der Isar der Technischen Universität München (TUM) clinical team has treated the first cancer patients in Germany with the innovative Radixact® System. This next-generation helical radiation therapy technology replaced an existing, earlier generation TomoTherapy® System at TUM, reinforcing its value to the hospital as a workhorse radiation therapy device capable of treating a wide range of indications from simple to complex. The TUM patients were treated for breast cancer, head and neck tumors, prostate cancer and spinal tumors.

The TUM hospital is focused on providing patients with personalized care using state-of-the-art technology that can deliver high-precision radiation therapy with minimal side effects. The specialized team of experts in radiation therapy and medical physics, and specially trained medical-technical radiology assistants, work closely with other disciplines within the university hospital, referring physicians, and other institutions, to ensure patients receive the best possible treatment for their specific type of cancer.

"Our radiotherapy team has been using the TomoTherapy platform for more than 10 years and have found it to be an essential component of cancer care at the hospital. When it came time to purchase a new radiation therapy device, our long-term positive experiences made the decision to upgrade to the Radixact System an easy one," said Univ. Prof. Dr. med. Stephanie E. Combs, Chair of the Department of Radiation Oncology at Klinikum rechts der Isar Technische Universität München. "We treat patients with a wide variety of tumor types and are excited about the opportunity to treat even complex cases much more quickly, without sacrificing precision or accuracy. In the future, we look forward to improved image guidance, and motion tracking and compensation, enhancements that we believe will enable us to significantly improve patient care."
State-of-the-art technology is designed to empower clinicians to improve their patients' care

The system is fully-integrated with the Accuray Precision® Treatment Planning System and the iDMS™ Data Management System, enabling the clinical team to increase the ease and speed with which they create treatment plans and deliver precise radiation treatments
The Radixact System delivers the same highly conformal and homogeneous dose distribution faster than the previous TomoTherapy platform, with a higher dose rate (1000 MU/minute) and imaging time that is 66 percent faster. A combination of higher dose output and faster image acquisition can shorten treatment times, while improving the patient experience

Rad Oncology Homepage